Eli Lilly | LLY - Trade Debtors

Stock Price
1,020.84
Daily Change
-86.28 -7.79%
Monthly
-4.06%
Yearly
17.29%
Q1 Forecast
1,005.21

Eli Lilly reported $19.46B in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Abbott USD 10.4B 166M Sep/2025
ALKERMES USD 355.11M 1.22M Sep/2025
Amgen USD 8.49B 211M Sep/2025
AstraZeneca USD 17.56B 1.32B Sep/2025
Baxter International USD 1.77B 127M Jun/2025
Biogen USD 1.85B 234M Sep/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Drreddys Laboratories INR 1.41B 11.6M Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Gilead Sciences USD 5.1B 314M Sep/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Glaxosmithkline GBP 11.16B 3.46B Sep/2025
J&J USD 17.61B 235M Sep/2025
Medtronic USD 6.26B 252M Jun/2025
Merck USD 12.12B 596M Sep/2025
Neurocrine Biosciences USD 728M 132.3M Sep/2025
Novartis USD 8.98B 192M Sep/2025
Novartis USD 8.98B 192M Sep/2025
Novo Nordisk DKK 95.05B 2.4B Dec/2025
Perrigo USD 644.4M 62.2M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
Prestige Brands USD 190.46M 8.54M Dec/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Sanofi EUR 397M 100M Dec/2025
Sanofi EUR 397M 186.13M Dec/2025
United Therapeutics USD 297.7M 81.6M Sep/2025
Zoetis USD 1.54B 1000K Sep/2025